Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods and compositions related to RNA-targeted Rho small GTPase RND3/RhoE therapy

US Patent 12129470 · Granted Oct 29, 2024

Estimated economic value: $542,543,000

Assignee

Inventors

View full patent text on Google Patents →